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ABSTRACT Deletion of copper-zinc superoxide dis-
mutase (CuZnSOD) in Sod1/ mice leads to acceler-
ated loss of muscle mass and force during aging, but
the losses do not occur with muscle-specific deletion of
CuZnSOD. To determine the role of motor neurons in
the muscle decline, we generated transgenic Sod1/
mice in which CuZnSOD was expressed under control
of the synapsin 1 promoter (SynTgSod1/ mice). Syn-
TgSod1/ mice expressed CuZnSOD in brain, spinal
cord, and peripheral nerve, but not in other tissues.
Sciatic nerve CuZnSOD content in SynTgSod1/ mice
was 20% that of control mice, but no reduction in
muscle mass or isometric force was observed in SynTg-
Sod1/ mice compared with control animals, whereas
muscles of age-matched Sod1/ mice displayed 30–
40% reductions in mass and force. In addition, in-
creased oxidative damage and adaptations in stress
responses observed in muscles of Sod1/ mice were
absent in SynTgSod1/ mice, and degeneration of
neuromuscular junction (NMJ) structure and function
occurred in Sod1/ mice but not in SynTgSod1/
mice. Our data demonstrate that specific CuZnSOD
expression in neurons is sufficient to preserve NMJ and
skeletal muscle structure and function in Sod1/ mice
and suggest that redox homeostasis in motor neurons
plays a key role in initiating sarcopenia during aging.—
Sakellariou, G. K., Davis, C. S., Shi, Y., Ivannikov,
M. V., Zhang, Y., Vasilaki, A., Macleod, G. T., Richard-
son, A., Van Remmen, H., Jackson, M. J., McArdle, A.,
Brooks, S. V. Neuron-specific expression of CuZnSOD
prevents the loss of muscle mass and function that
occurs in homozygous CuZnSOD-knockout mice.
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Aging of skeletal muscle is characterized by loss of
mass and contractile force, which has a profound effect
on the quality of life of older people (1). Loss of
skeletal muscle begins in middle age and continues
until the end of life (2). Studies of humans indicate that
by the age of 70, there is a 25–30% reduction in the
cross-sectional area (CSA) of skeletal muscle and a
decline in muscle strength of 30–40% (3). The age-
related reduction in the muscle fiber size and number
(4) is a slow process with a complex and multifactorial
etiology.
One factor in numerous tissues that is clearly associ-
ated with loss of function during aging is oxidative
damage, and experimental evidence from humans and
rodents has shown that skeletal muscles exhibit age-
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dependent increases in the products of oxidative dam-
age to biomolecules including proteins, lipids, and
nucleic acids (5–8). Recent reports have attributed the
positive correlation between age and oxidative damage
to age-related changes in production of reactive oxygen
and nitrogen species (RONS), with skeletal muscles
from old mice exhibiting a higher intracellular RONS
generation in comparison to muscles from young mice
(9, 10). The hypothesis that increased generation of
oxidants in vivo plays a key role in age-related muscle
dysfunction has been examined in transgenic and
knockout mouse models, and work from our group has
shown that deletion of the superoxide scavenging en-
zyme copper-zinc superoxide dismutase (CuZnSOD) in
mice (Sod1/ mice) induces an accelerated skeletal
muscle aging phenotype (11–15). Many features of the
muscles of Sod1/ mice, including elevated oxidative
damage, loss of contractile force, degeneration of neu-
romuscular junctions (NMJs), and loss of innervation
resemble those observed in old wild-type (WT) mice
(11–15). Hence, this knockout mouse represents a
useful model for the study of the role of chronic
oxidative stress in the loss of skeletal muscle that occurs
with aging.
Elucidation of the primary mechanisms underlying
sarcopenia has been challenging, in part because of
the difficulty in unraveling the interplay between loss
of muscle mass and loss of functional motor units,
both of which occur with aging (16). Several exper-
imental studies have demonstrated that manipula-
tions that modify the integrity of NMJs lead to a
phenotype that resembles the age-related loss of
muscle mass and function (17–19). In addition,
skeletal muscle atrophy in Sod1/ mice is associated
with NMJ alterations, including motor axon degen-
eration and postsynaptic end plate fragmentation
(11, 20), indicating that NMJ degeneration may be a
critical part of the muscle atrophy phenotype exhib-
ited in the Sod1/ mouse model; however, whether
these degenerative changes are initiated by changes
in redox homeostasis proximal and/or distal to the
neuromuscular synapses is not known. To begin to
tackle questions regarding the relative importance of
pre- and postsynaptic changes in redox homeostasis,
we recently examined whether specific Sod1 gene
deletion targeted to skeletal muscle leads to muscle
atrophy and showed that absence of CuZnSOD
within the muscle tissue alone is not sufficient to
induce muscle atrophy (21). These results therefore
indicate that the muscle atrophy observed during
aging of Sod1/ mice is not primarily due to a
deficiency in CuZnSOD in skeletal muscle; instead,
failure of redox homeostasis in motor neurons may
be the primary initiating factor.
To directly test whether the muscle atrophy phe-
notype exhibited by the Sod1/ mice is related to
redox changes in motor neurons, we generated a
transgenic Sod1/ mouse model in which CuZnSOD
was expressed specifically in neurons under the
control of the synapsin 1 promoter (SynTgSod1/
mice). We hypothesized that if alterations in redox
homeostasis within the motor neurons were the
primary initiators of muscle atrophy, CuZnSOD-tar-
geted expression in the nerve of Sod1/ mice would
prevent the overt phenotypic changes of accelerated
skeletal muscle aging. In the present study we report
the effects of nerve-specific rescue of CuZnSOD in
Sod1/ mice on muscle mass, morphology and
function, oxidative damage, adaptive responses, and
NMJ structure and function.
MATERIALS AND METHODS
Animals
All mice were generated at the University of Texas Health
Science Center at San Antonio (UTHSCSA) as described
below. In San Antonio, the mice were maintained under
specific pathogen-free (SPF) conditions until they reached
appropriate ages for the electrophysiological studies per-
formed in San Antonio or were shipped to the University of
Michigan (UM) for measurement of contractile properties
and harvesting of tissues for histologic, biochemical, and
molecular analyses. The mice were shipped at 12 mo of
age and maintained under SPF conditions in the Unit for
Laboratory Animal Medicine at UM until they were tested
at an average age of 15.6  0.4 mo. At both sites, the mice
were fed standard NIH-31 chow ad libitum and were main-
tained under barrier conditions in microisolator cages on a
12-h dark/light cycle. For simple tissue collection, the mice
were euthanized by CO2 inhalation followed by cervical
dislocation, and the muscles and tissues were rapidly
removed, snap-frozen, and stored at 80°C until analysis.
For measurement of contractile properties, the mice were
anesthetized with intraperitoneal injections of tribromo-
ethanol (400 mg/kg), with supplemental injections pro-
vided to maintain an adequate level of anesthesia through-
out the procedure. For in vivo electromyography studies,
the mice were anesthetized with isoflurane. All procedures
were approved by both the University Committee on the
Use and Care of Animals at UM and the Institutional
Animal Care and Use Committee at UTHSCSA and were in
accordance with the U.S. National Institutes of Health
(NIH) Guide for Care and Use of Laboratory Animals
(Public Health Service 19965, NIH Publication 85-23).
Generation of a Sod1 nerve rescue Sod1/ mouse model
(SynTgSod1/)
Details of the generation and characterization of the Sod1/
mouse model have been reported previously (13, 22, 23). For
the present study, a transgenic mouse model with neuron-
specific expression of human SOD1 (hSOD1) was generated
on the C57BL/6 genetic background by using a transgene
construct containing the hSOD1 cDNA driven by a neuron-
specific synapsin promoter. The rescue mice were generated
by crossing synapsin hSOD1 transgenic mice with Sod1/
mice, resulting in mice with expression of hSOD1 restricted
to neuronal tissue and completely lacking endogenous mouse
Sod1 expression. To confirm the nerve-specific Sod1 expres-
sion, a variety of tissues were dissected and assayed for hSOD1
protein.
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Muscle function analyses
Gastrocnemius (GTN) muscle contractile properties were
measured in situ, as described by Larkin et al. (12). In
anesthetized mice, the whole GTN muscle was isolated
from surrounding muscle and connective tissue, and the
distal tendon was severed and secured to the lever arm of
a servomotor (model 305B; Aurora Scientific Inc., Aurora,
ON, Canada). A continual drip of saline warmed to 37°C
was applied to the GTN muscle to maintain its tempera-
ture. The muscle was activated by stimulation of the tibial
nerve with a bipolar platinum wire electrode. The voltage
of single 0.2 ms stimulation pulses was adjusted to give a
maximum isometric twitch. Subsequently, muscle length
was adjusted to the optimal length (Lo) at which twitch
force was maximal. With the muscle held at Lo, 300-ms
trains of pulses were applied at increasing stimulation
frequencies until the maximum isometric tetanic force (Po)
was achieved. The same procedure was then repeated, but,
rather than activating the muscle via the tibial nerve, a cuff
electrode was placed around the proximal and distal ends
of the muscle for direct muscle stimulation. After force
measurements, the GTN, anterior tibialis (AT), extensor
digitorum longus (EDL), soleus (SOL), quadriceps
(Quad), and plantaris (PLT) muscles were removed, and
the deeply anesthetized mice were euthanized by pneumo-
thorax. All muscles were trimmed off their tendons, blot-
ted, and weighed. The muscles were either snap-frozen for
protein or molecular analyses or coated in tissue-freezing
medium (Triangle Biomedical Sciences, Durham, NC,
USA) and rapidly frozen in isopentane cooled with liquid
nitrogen for histologic analysis. GTN muscle fiber length
(Lf) was calculated by multiplying Lo by 0.45. Total fiber
CSA was calculated by dividing the muscle mass (in milli-
grams) by the product of Lf (in millimeters) and the
density of mammalian skeletal muscle, 1.06 g/cm2. Specific
Po (newtons per square centimeter) was calculated by
dividing Po by total fiber CSA for each muscle.
In vivo electromyography (EMG)
Anesthetized animals were maintained at 33–34°C under a
heat lamp. All experiments were performed by the Nicolet
Viking Quest portable EMG apparatus (CareFusion, San
Diego, CA, USA). The repetitive nerve stimulation (RNS)
assay was performed according to the methods of Kaja et al.
(24), with minor modifications. The evoked compound
muscle action potentials (CMAPs) from the GTN were
recorded with a subdermal electrode inserted at the mid-
belly region, and the stimulating electrode was inserted
near the sciatic nerve in the thigh. The reference electrode
was placed at the ankle. Trains of 10 stimuli were applied at
various frequencies (0.2, 3, 5, and 10 Hz) with a 2 min
recovery period. The CMAP decrement was reported as the
percentage difference between the amplitude of the fifth
evoked CMAP with the first CMAP.
Electrophysiological recordings from muscle
Intracellular recordings of miniature end plate potentials
(mEPPs) and evoked end plate potentials (EPPs) in the
EDL muscle were performed by standard techniques with a
high-impedance amplifier (Axoclamp 900A; Molecular De-
vices, Sunnyvale CA, USA). For the EDL dissection, either
the left or right hind limb was shaved and skinned. After
removal of the biceps femoris muscle and sciatic nerve
dissection, a complex of the EDL and AT muscles was
dissected and pinned by the tendons to a dish. Recording
microelectrodes were filled with a solution mix containing
1.5 M KCl and 1.5 M KAc, to give a final resistance of
40 –50 M. Data were digitized and recorded with Chart
5.5.6 software (AD Instruments, Colorado Springs CO,
USA). To prevent muscle contractions, 1 M -conotoxin
was added to the recording solution (standard Kreb’s
solution continuously perfused with a 95% O2/5% CO2 gas
mixture). Offline data analysis was performed with
pCLAMP 10 (Molecular Devices).
CuZnSOD and manganese superoxide dismutase (MnSOD)
enzymatic activity assays
The activities of CuZnSOD and MnSOD were measured in
native gels, with negative staining, as described previously
(25). The gel image was scanned and recorded with an Alpha
Imager 3400 (Alpha Innotech, San Leandro, CA, USA) and
analyzed with ImageQuant Software (GE Healthcare Life
Sciences, Sunnyvale, CA, USA).
Lipid peroxidation assay
Lipid peroxidation was assessed in mouse skeletal muscle
and brain by determining the levels of F2-isoprostanes by
our published method (26). Mouse tissue (200 mg) was
homogenized, and whole lipid was extracted with chloro-
form-heptane. The levels of F2-isoprostanes from brain and
muscle tissue (esterified) were measured by gas chroma-
tography-mass spectrometry (GC-MS), as previously de-
scribed (26) and initially described by Morrow et al. (27).
The levels of F2-isoprostanes are expressed as nanograms
F2-isoprostanes (8-iso-PGF2) per gram tissue.
Ultrastructural analysis by electron microscopy (EM)
GTN muscles were dissected, carefully cut into 1-  2-mm
fragments, and incubated overnight with 2.5% glutaralde-
hyde in 0.1 M Sorensen’s buffer (pH 7.4). The samples were
then rinsed 3 times for 15 min each in 0.1 M Sorensen’s
buffer and stored at 4°C. The tissue was postfixed for 1 h in
1% osmium tetroxide in the same buffer, rinsed in Sorensen’s
buffer, and dehydrated in ascending concentrations of etha-
nol, transitioned through propylene oxide, and infiltrated
into and embedded in Epon epoxy resin. The tissue was
ultrathin sectioned (70 nm), mounted on copper grids, and
poststained with uranyl acetate and lead citrate. The sections
were examined with a CM-100 transmission electron micro-
scope at 60 kV (Philips, Eindhoven, The Netherlands). The
images were recorded digitally with an ORCA-HR digital
camera system (Hamamatsu, Hamamatsu City, Japan), oper-
ated by AMT software (Advanced Microscopy Techniques
Corp., Danvers, MA, USA).
Immunohistochemistry (IHC) of the NMJs
To visualize the NMJs, AT muscles from Sod1/, WT, and
SynTgSod1/ mice were fixed in 4% paraformaldehyde
(PFA) for 30 min and sectioned on a cryostat (Bright
Instrument Co., Huntingdon, UK). The longitudinal sec-
tions (35 m) were blocked and permeabilized in PBS, 4%
BSA, and 1% Triton X-100 for 3 h at 25°C and then
incubated with the primary antibodies anti-pan-axonal
neurofilament marker (Covance, Princeton NJ, USA) and
synaptotagmin 2 (Abcam, Cambridge, UK) for 36 h in 4%
BSA and 1% Triton X-100 in PBS at 4°C. The sections were
then washed for 2 h in PBS and incubated for 2 h at 25°C
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with secondary antibody (488 anti-mouse IgG; Invitrogen,
Carlsbad CA, USA) and AlexaFluor 594-conjugated bunga-
rotoxin (Molecular Probes, Eugene, OR, USA) diluted in
PBS, 4% BSA, and 1% Triton X-100. After the sections were
washed for 1 h in PBS, they were mounted in Vectashield
(Vector Laboratories, Peterborough, UK), and immunoflu-
orescence images of the NMJs were obtained on an LSM
510 Meta confocal microscope (Zeiss GmbH, Oberkochen,
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Figure 1. Generation of Sod1 neuron rescue Sod1/ mice (SynTgSod1/). A) Schematic for generating Syn-hSOD1 transgenic
mice and breeding to Sod1/ mice to generate SynTgSod1/ mice. B, C) Western blot analysis of SOD1 content of the AT (B)
and GTN (C) muscles of Sod1/, WT, and SynTgSod1/ mice. D, E) Western blot analysis of SOD1 (D) and SOD2 (E) content
of sciatic nerve (SN) of Sod1/, WT, and SynTgSod1/ mice and densitometric quantification of the blots. *P  0.05 vs. WT.
F) Western blot analysis of the SOD1 content of the spinal cord (SC) of WT, Sod1/, and SynTgSod1/ mice and densitometric
quantification of the blots. *P  0.05 vs. WT. G) Representative Western blot of the SOD1 content of the liver of Sod1/, WT,
and SynTgSod1/ mice. H–J) Native gels stained for SOD1 and SOD2 enzyme activities in skeletal muscle (H), brain (I), and
spinal cord (J) from WT, Sod1/, and SynTgSod1/ mice. K) Transverse sections of lumbar spinal cord dorsal horn from WT,
Sod1/, and SynTgSod1/ mice labeled with human SOD1 (green) and GFAP (red), a marker of astrocytes. Nuclei (blue)
were labeled with DAPI (100).
(continued on next page)
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Germany) and analyzed with ZEN acquisition software
(Zeiss).
IHC of spinal cords
Mice were perfused with 4% PFA, and the spinal cords were
dissected and placed in 4% PFA overnight. The tissues were
then transferred to glucose for 48 h. After cryosectioning,
transverse lumbar spinal cord sections of 20 m thickness
were permeabilized in 0.1% Tween-20 in PBS for 5 min and
blocked in PBS, 5% BSA for 1 h. The sections were probed
with primary antibodies and incubated overnight at 4°C. The
following antibodies were used: anti-glial fibrillary acidic
protein (GFAP; Cell Signaling, Danvers, Mass, USA) and
anti-CuZnSOD (Enzo Life Sciences, Ltd., Exeter, UK). The
sections were washed 3 times for 5 min each in PBS and
counterstained for 1 h at 25°C with AlexaFluor-conjugated second-
ary antibodies (Molecular Probes) diluted in PBS and 5% BSA.
They were then washed again (35 min in PBS) and
mounted on slides with Prolong Gold Antifade reagent
containing DAPI (Molecular Probes). Spinal cord immuno-
fluorescence images were visualized with an Eclipse
TE2000-U fluorescence microscope (Nikon Inc., Tokyo, Ja-
pan).
Western blot analysis of muscle proteins
For assessment of specific proteins in muscle, 30 g of total
protein was applied to an 8 –15% polyacrylamide gel with a
4% stacking gel (National Diagnostics Ltd., Atlanta, GA,
USA). The separated proteins were transferred onto nitro-
cellulose membranes by Western blot analysis. The mem-
branes were probed with antibodies against CuZnSOD
(SOD1) and MnSOD (SOD2) (Stressgen Inc., Victoria, BC,
Canada); heat-shock protein (HSP)25, HSP60, and heat
shock cognate (HSC)70 (Enzo Life Sciences); slow myosin
heavy chain (MyHC; Sigma-Aldrich, Poole, UK); nNOS,
eNOS, iNOS, HSP10, HSP72, peroxiredoxin V (PRXV),
Fast MyHC, and GAPDH (Abcam, Cambridge, UK) (28).
Horseradish peroxidase– conjugated anti-mouse IgG, anti-
rabbit IgG (Cell Signaling Technologies, Hitchin, UK) or
anti-rat (Sigma-Aldrich) was used as the secondary anti-
body. Peroxidase activity was detected with an ECL kit
(Amersham International, Cardiff, UK), and band intensi-
ties were analyzed by Quantity One Software (Bio-Rad
Laboratories Ltd., Hemel Hempstead, UK). The specificity
of the bands was identified in comparison with a sample
that had not been exposed to the primary antibody, and
the molecular mass was determined by using molecular
mass markers. The NF	B subunits p50 and p65 were
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analyzed on nuclear protein extracts that were isolated
from skeletal muscle (15). All protein contents were nor-
malized to the GAPDH or 
-actin content of the same
sample.
Analyses of the 3-nitrotyrosine (3-NT) content of muscle
proteins
Total cellular protein was isolated, and 30 g was separated
by SDS-PAGE followed by Western blot analysis, as describe
above. The separated proteins were transferred onto poly-
vinylidene difluoride (PVDF) membranes. The content of
3-NT was analyzed by using a rabbit monoclonal antibody
(Cell Biolabs, San Diego, CA, USA), according to manu-
facturer’s instructions. The bands were visualized, and
densitometric quantification was undertaken with a Chemi-
Doc XRS System (Bio-Rad Laboratories, Hercules, CA,
USA; ref. 14).
Determination of muscle structure
GTN muscles were cryosectioned at a thickness of 12 m at
28°C through the midbelly, and fluorescent IHC staining
was initiated the same day. Sections were rinsed with PBS
and permeabilized in 0.2% Triton X-100 in PBS for 5 min.
Wheat germ agglutinin (WGA) lectin AlexaFluor 488 (Mo-
lecular Probes) was used to identify extracellular matrix.
Nuclei were identified with DAPI. Cross sections from 3–5
muscles/genotype were examined by observers in a blinded
procedure to count the number of fibers with centrally
located nuclei and to quantify individual fiber CSAs. For each
of these analyses, 5 random fields/cross section with 300–
400 fibers/field were counted for a total of 1500–2000
fibers/sample analyzed. ImageJ software (NIH, Bethesda,
MD, USA) was used to measure individual fiber CSAs.
Real-time PCR analysis
Total RNA was isolated from GTN muscles by using Trizol
reagent (Life Technologies, Gaithersburg, MD, USA) accord-
ing to the manufacturer’s instructions. cDNA was reverse
transcribed, and gene expression was measured by SYBR
Green assay and quantified by the 2Ct method. The
primer sequences are as follows: acetylcholine receptor -sub-
unit (AChR), forward ACCTGGACCTATGACGGCTCT, re-
verse AGTTACTCAGGTCGGGCTGGT; and -actin, forward
GCCGCCGCGTCCTT, reverse ATGACGAGTGCGGCGATT.
The fold change in expression compared to WT values was
calculated and plotted.
Statistical analysis
Data are presented as means  sem for each experiment.
Comparisons between genotypes were performed by 1-way
ANOVA followed by the post hoc LSD test. Data were
analyzed with SPSS 18 (SPSS Inc., Chicago, IL, USA).
Values of P  0.05 were considered statistically significant.
RESULTS
Generation of Sod1 neuron rescue Sod1/
(SynTgSod1/) mice
As described in Materials and Methods and demon-
strated by the data shown in Fig. 1, crossing of
Sod1/ mice with transgenic mice in which the
human CuZnSOD protein was specifically expressed
in neurons under control of the synapsin 1 promoter
produced mice (SynTgSod1/) with neuron-specific
Sod1 expression. To confirm the targeted rescue of
the Sod1 gene in neurons, several tissues, including
the AT (Fig. 1B) and GTN muscles (Fig. 1C), sciatic
nerve (Fig. 1D, E), spinal cord (Fig. 1F), and liver
(Fig. 1G) were dissected after the mice were eutha-
nized, and the CuZnSOD protein content was exam-
ined. Expression of CuZnSOD protein in the SynTg-
Sod1/ mice was found in the sciatic nerve (Fig. 1D)
and spinal cord (Fig. 1F), but not in the muscle tissue
(Fig. 1A, B) or liver (Fig. 1G). The molecular masses
of human and mouse CuZnSOD are 23 and 19 kDa,
respectively, and this difference in molecular mass of
the transgenic SOD1 can be seen in Fig. 1D. CuZn-
SOD protein content in sciatic nerve (Fig. 1D) and
spinal cord (Fig. 1F) of the SynTgSod1/ mice was
on the order of 20 – 60% of the levels observed in
these tissues in WT mice. In contrast, the SynTg-
Sod1/ mice exhibited 2-fold overexpression of
hSOD1 in brain compared with endogenous Sod1
expression in the WT mice (data not shown).
Sod1/ mice showed no evidence of CuZnSOD
expression in any tissues. MnSOD, the mitochondrial
SOD isoform, was detected in the sciatic nerves from
the Sod1/, WT, and SynTgSod1/ mice, but no
significant differences in content were seen between
genotypes (Fig. 1E). The neuron-specific expression of
CuZnSOD in the SynTgSod1/ mice was further con-
firmed by enzymatic activity assays. As shown in Fig.
1H–J, CuZnSOD activity was evident only in the brain
(Fig. 1I) and spinal cord (Fig. 1J) of the SynTgSod1/
mice; the skeletal muscles from these mice showed no
detectable CuZnSOD activity. The activity of MnSOD in
muscle of the SynTgSod1/ mice was unchanged com-
pared with that in the WT mice, indicating that no
compensatory up-regulation of MnSOD had occurred
in response to the absence of CuZnSOD in the skeletal
muscle of the SynTgSod1/ mice (Fig. 1H). To further
assess neuron-specific hSOD1 expression, we per-
formed IHC studies of the spinal cords (Fig. 1K).
hSOD1 was absent in the WT and Sod1/ mice but was
Table 1. Body and skeletal muscle masses of WT, Sod1/, and
SynTgSod1/ mice
Tissue WT Sod1/ SynTgSod1/
Body weight (g) 30.9  1.2 28.1  1.7 29.8  2.5
AT (mg) 51.3  1.5 34.2  2.9* 50.9  1.7
EDL (mg) 10.8  0.2 8.4  0.7* 10.2  0.5
GTN (mg) 146.1  7.0 72.4  9.3* 139.7  8.1
SOL (mg) 7.8  0.5 8.4  0.7 9.5  0.5
Quad (mg) 246.1  9.9 136.0  13.3* 228.5  10.9
PLT (mg) 15.7  1.1 7.3  2.7* 13.6  1.0
Values are presented as means  sem; n  5/group. *P  0.05
vs. WT.
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highly expressed in the SynTgSod1/ mice. In addi-
tion, immunofluorescence imaging with double label-
ing for hSOD1 and GFAP, a well-characterized marker
of astrocytes, indicated no colocalization of hSOD1
with astrocytes, supporting the specific expression of
the Sod1 transgene under the synapsin promoter in
neurons rather than in nonneuronal glial cells in the
Sod1 neuron rescue Sod1/ mice.
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Changes in muscle mass and morphology in
SynTgSod1/ mice
We showed previously (13) that loss of skeletal muscle
mass in the Sod1/ mice occurs as early as 3 mo of age.
To determine whether neuron-specific expression of
CuZnSOD in the rescue SynTgSod1/ mice would
prevent the loss of muscle mass that occurs in Sod1/
mice, body weight and the mass of several skeletal
muscles were studied. No differences in body weight
were observed between genotypes in this study (Table 1).
Thus, absolute muscle masses are presented (Table 1).
As previously reported, mass was substantially reduced
in muscles of the Sod1/ mice compared with that in
WT muscles, with the sole exception of the SOL
muscles, which were not different between the geno-
types. In contrast to the Sod1/ mice, which had lower
muscle masses, the SynTgSod1/ mice showed no
evidence of atrophy in the AT, EDL, GTN, Quad, or
PLT muscles (Table 1). To examine the structure of
skeletal muscle, we obtained transverse sections of the
GTN muscles from WT, Sod1/, and SynTgSod1/
mice (Fig. 2A). Sections of muscles of the Sod1/ mice
showed variability in fiber size and the presence of a
substantial number of fibers containing centrally lo-
cated nuclei, in agreement with prior results (20).
Fibers with centrally located nuclei were rarely detect-
able in the WT mice (Fig. 2A), but the presence of
occasional central nuclei was observed in the GTN
muscle fibers from the SynTgSod1/ mice (Fig. 2A).
Quantification of the number of fibers with centrally
located nuclei in the SynTgSod1/ mice indicated that,
whereas the number of centrally nucleated fibers was
greater in the muscles of the Sod1/ mice than in
those of the WT mice, the number was not significantly
elevated in the SynTgSod1/ mice compared with
control values (Fig. 2B). As we have shown for Sod1/
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and WT mice at 8 and 20 mo of age (12), average fiber
CSA for GTN muscles did not differ significantly in the
WT, Sod1/, and SynTgSod1/ mice (Fig. 2C). How-
ever, quantitative analysis of individual fiber CSAs re-
vealed that the myofiber size distribution shifted to the
left in the Sod1/ mice, suggesting that smaller fibers
were more prevalent in muscle of those mice (Fig. 2D).
In addition, no differences were observed between the
WT and SynTgSod1/ mice, indicating that the ab-
sence of CuZnSOD in skeletal muscle of SynTgSod1/
mice did not induce muscle fiber size changes (Fig.
2D). Similarly, no changes in slow (Fig. 2E) and fast
(Fig. 2F) MyHC content was seen between muscles from
the WT and SynTgSod1/ mice, implying no changes
in fiber type composition, a finding that was confirmed
by IHC (data not shown). Previously, we showed that
the absence of CuZnSOD in Sod1/ mice alters the
ultrastructure of myofibrils, as shown by abnormally
organized sarcomeres and clustered mitochondria
(11). In contrast, muscles of the SynTgSod1/ mice
showed no changes in myofibrillar organization or
mitochondrial accumulation compared with muscles of
the WT mice (Fig. 2G).
Muscle function is preserved in SynTgSod1/ mice
To determine whether rescue of the Sod1 gene in
neurons of the SynTgSod1/ mice was sufficient to
alter muscle function, we measured maximum isomet-
ric force generated by GTN muscles in situ in response
to nerve stimulation. As shown in Fig. 3A, maximum
isometric-specific force of GTN muscle was reduced by
30% in the Sod1/ mice compared with the WT mice,
whereas muscles from the SynTgSod1/ mice showed
no evidence of impaired muscle force generation. To
determine the overall function of NMJs, maximum
isometric contractions were also elicited by direct stim-
ulation of the muscle tissue. No changes in maximum
force generation were observed in muscles of the
SynTgSod1/ or WT mice (Fig. 3B), whereas a signifi-
cant increase in force generation was found in the
Sod1/ mice after direct muscle stimulation. Thus,
these data indicate that rescue of the CuZnSOD in
neurons of Sod1/ mice restores full functional inner-
vation to the GTN muscle.
Muscle redox status is not affected in skeletal
muscles from SynTgSod1/ mice deficient of
CuZnSOD
To determine the effect of rescue of CuZnSOD in
neurons on oxidative damage to SynTgSod1/ mice,
we measured the content of F2-isoprostanes, an indica-
tor of lipid peroxidation, and found no difference in
GTN muscle between the SynTgSod1/ and WT mice
(Fig. 4A). Similarly, no differences were observed in the
contents of F2-isoprostanes in the brains from SynTg-
Sod1/ and WT mice. Both tissues (GTN and brain)
from Sod1/ mice showed a significant increase in
F2-isoprostanes compared with age-matched WT mice
(Fig. 4A) indicating an increase in lipid peroxidation.
The level of protein nitration (Fig. 4B) and the protein
content of PRXV, a peroxynitrite reductase, was also
unchanged in skeletal muscle from the SynTgSod1/
and WT mice (Fig. 4C), indicating no change in the
overall redox status in the muscle of the SynTgSod1/
mice. In contrast, skeletal muscle from the Sod1/
mice showed a significant increase in both protein
nitration (Fig. 4B) and PRXV expression (Fig. 4C),
potentially reflecting an increase in peroxynitrite activ-
ity in skeletal muscle of the SOD1-null mice, as previ-
ously observed (14).
No compensatory up-regulation in regulatory enzymes
for RONS, stress responses, and adaptive signaling
pathways in SynTgSod1/ mice
The accelerated skeletal muscle-aging phenotype ob-
served in Sod1/ mice has been associated with in-
creased oxidative damage and altered redox markers
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including an up-regulation in HSP expression and in-
creased NF	B activation (15). To determine whether
restoration of the neuron SOD1 in the absence of muscle
SOD1 in SynTgSod1/ mice might lead to a compensa-
tory change in the expression or activity of proteins
involved in antioxidant defense, we measured the expres-
sion of RONS regulatory enzymes and proteins in mus-
cles. As shown in Fig. 5, no significant changes were
detected in the RONS regulatory enzymes, including nNOS,
eNOS, iNOS, and MnSOD, in muscle tissue of the SynTg-
Sod1/mice compared with that of the WT mice. Muscle of
the Sod1/ mice showed a significant increase in the
content of eNOS (Fig. 5B) and iNOS (Fig. 5C), compared
with muscle from the WT mice. No significant difference was
seen in the content of MnSOD in Sod1/ muscle, com-
pared with that in WT or SynTgSod1/ muscle (Fig. 5D).
HSPs have been shown to provide protection against
an increase in RONS production (5), and we have
shown elevated HSP content in muscle from Sod1/
mice (15). We examined whether the content of various
HSPs (Fig. 6) and markers of NF	B activation (Fig. 7)
were altered in skeletal muscle of the SynTgSod1/
mice in comparison with that of the Sod1/ and WT
mice. Protein expression of HSP10 (Fig. 6A), HSP25
(Fig. 6B), and HSC70 (Fig. 6E) was unchanged in the
muscles of the SynTgSod1/ mice, compared with
expression in the WT muscle, but muscles from the
Sod1/ mice had an increased content of HSP25 (Fig.
6B), HSP60 (Fig. 6C), and HSP72 content (Fig. 6D).
Interestingly, there was evidence of HSP60 down-regu-
lation (Fig. 6C) in muscle from the SynTgSod1/ mice
compared with both other groups. Inducible HSP72
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was not detected in skeletal muscle from the rescue and
WT mice (Fig. 6D). Thus, rescue of neuron CuZnSOD
in SynTgSod1/ mice prevented the compensatory
increases in HSPs that occurred in the whole-body
SOD1-knockout mice. Previous data indicate that the
NF	B signaling pathway is activated in muscle from
Sod1/ mice, but muscle from SynTgSod1/ mice
showed no evidence of this, as assessed by nuclear
translocation of the NF	B cleavage products p50 and
p65 (Fig. 7). Nuclear p50 (Fig. 7B) and p65 (Fig. 7C)
contents were unchanged between the SynTgSod1/
and WT mice.
Neuron-specific expression of CuZnSOD in
SynTgSod1/ mice preserves NMJ structure and
function
Based on our observation that neuron-specific expression
of CuZnSOD prevents the losses of muscle mass and
function that occur in Sod1/ knockout mice (Fig. 2 and
3), we hypothesized that rescue of CuZnSOD expression
in motor neurons would also preserve motor neurons and
NMJ structure and function. To test this hypothesis, we
examined NMJ structure via immunofluorescent staining
techniques (Fig. 8A). Motor neuron axons were stained
with antibodies to neurofilaments and synaptotagmin 2
(NF/Syt2), whereas the motor end plates were identified
with fluorophore-conjugated bungarotoxin, which stains
the subunit of the postsynaptic nicotinic AChRs. As shown
in Fig. 8A, immunohistologic examination of NMJs from
the Sod1/ mouse model exhibited abnormal axons and
fragmented postsynaptic end plates (Fig. 8A). In compar-
ison, NMJs in the SynTgSod1/ mice showed no evidence
of marked alterations, compared with those in the NMJs
of the age-matched WT mice, indicating that rescue of
CuZnSOD specifically in neurons restores both pre-
synaptic and postsynaptic NMJ structure. Analysis of
the content of mRNA for AChR- in muscles was
undertaken to examine the effect of restoration of
neuronal CuZnSOD on AChR turnover in Sod1/
mice. The AChR- mRNA content was increased in
muscle from the Sod1/ mice, but was unchanged in
the SynTgSod1/ mice in comparison with that in the
WT (Fig. 8B). Experiments to examine muscle electro-
physiological properties indicated that expression of
CuZnSOD exclusively in neurons in the Sod1/ mice
A
D
B
C
0
0.2
0.4
0.6
0.8 nNOS
WT SynTgSod1-/-Sod1-/-
R
el
at
iv
e 
pr
ot
ei
n
ex
pr
es
si
on
0
0.2
0.4
0.6
0.8
*
WT SynTgSod1-/-Sod1-/-
eNOS
R
el
at
iv
e 
pr
ot
ei
n
ex
pr
es
si
on
0
0.2
0.4
0.6
0.8
1 iNOS
*
WT SynTgSod1-/-Sod1-/-
R
el
at
iv
e 
pr
ot
ei
n
ex
pr
es
si
on
0
0.4
0.8
1.2 SOD2
WT SynTgSod1-/-Sod1-/-
R
el
at
iv
e 
pr
ot
ei
n
ex
pr
es
si
on
SOD2
GAPDH
- 25 kDa
- 36 kDa
WT SynTgSod1-/-Sod1-/-
iNOS
GAPDH
- 131 kDa
- 36 kDa
WT SynTgSod1-/-Sod1-/-
nNOS
GAPDH
- 160 kDa
- 36 kDa
WT SynTgSod1-/-Sod1-/-
GAPDH
- 133 kDa
- 36 kDa
WT SynTgSod1-/-Sod1-/-
eNOS
Figure 5. RONS regulatory protein contents in skeletal muscle of SynTgSod1/ mice. Representative Western blots of nNOS
(A), eNOS (B), iNOS (C), and SOD2 (D) protein content of skeletal muscles from Sod1/, WT, and SynTgSod1/ mice and
densitometric quantification of the blots. *P  0.05 vs. WT.
1676 Vol. 28 April 2014 SAKELLARIOU ET AL.The FASEB Journal  www.fasebj.org
resulted in an electrophysiological phenotype similar to
that of the WT animals (Fig. 8C). The amplitude of
evoked EPPs and the frequency of spontaneous mEPPs
in EDL muscle in the SynTgSod1/ mice were substan-
tially higher than those in the Sod1/ mice (unpub-
lished observations) and were comparable to those in
the WT mice (SynTgSod1/, EPP: 30.21.5 mV,
mEPP: 3.940.49 Hz, n6; WT, EPP: 27.51.0 mV,
mEPP: 3.770.28Hz, n22), suggesting that synaptic
vesicle release is fully restored by neuronal CuZnSOD
expression. Figure 8D shows the effect of repetitive
stimulation on the CMAP in the 3 groups of mice. At
increased stimulation frequency, muscles from the
Sod1/ mice showed a decrease in CMAP, but this was
not seen in the SynTgSod1/ or WT mice, demonstrat-
ing that restoration of CuZnSOD in neurons rescues
neurotransmission in SynTgSod1/ mice.
DISCUSSION
Considerable data have been presented examining the
possibility that changes in oxidative stress or a failure of
redox homeostasis play a role in aging processes.
Although the area remains controversial (29, 30), sub-
stantial evidence indicates that age-related losses of
skeletal muscle mass and function (sarcopenia) are
associated with increased oxidative damage to the tissue
and with activation of redox-regulated degenerative
pathways (10, 31). Our previous studies have demon-
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strated that mice lacking CuZnSOD in all tissues
(Sod1/) are characterized by an accelerated skeletal
muscle–aging phenotype that includes many features of
normal aging, such as loss of muscle fibers, weakness of
the remaining fibers, and degeneration of NMJs (11–
13). Muscles of Sod1/ mice also show increased
oxidative damage to lipids, proteins, and DNA, evi-
dence of adaptations in stress responses to RONS, and
defective redox signaling after contractile activity, all
features that are also seen in aged WT mice (13, 15).
We have therefore proposed that these mice can pro-
vide a mechanistic model to explore the processes by
which oxidative damage or defective redox signaling
can contribute to skeletal muscle aging.
Our group had previously refined the Sod1/
mouse model to examine the role of a muscle-specific
deletion of CuZnSOD in the accelerated muscle-aging
phenotype and generated surprising results. Mice with
muscle-specific deletion of the CuZnSOD gene main-
tained muscle masses at or above those of WT mice and
thus did not reproduce the phenotype seen in whole-
body Sod1/ mice (21). Our aim in the current study
was to examine the role of the deficit in CuZnSOD in
motor neurons in the muscle atrophy phenotype exhib-
ited by Sod1/ mice. Our approach was to generate a
neuron-specific transgenic Sod1/ mouse model in
which CuZnSOD was expressed in neurons under the
control of the synapsin 1 promoter (SynTgSod1/
mice). We hypothesized that if alterations in redox
homeostasis within the motor neurons were the pri-
mary initiators of muscle atrophy, then targeted expres-
sion of CuZnSOD in the nerve of Sod1/ mice would
at least partially prevent the accelerated, age-related
loss of muscle mass and function. SynTgSod1/ mice
showed no losses in muscle mass or maximum isometric
specific force production up to at least 15 mo of age, a
point in life when dramatic deficits in essentially all
measures of neuromuscular function were seen in
Sod1/ mice (11–13). Increased oxidative damage and
adaptations in stress responses observed in muscles
from Sod1/ mice (14, 15) were not present in
SynTgSod1/ mice. Finally, the accelerated degenera-
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tion in NMJ structure and function that occurred in
Sod1/ mice (11) was not seen in SynTgSod1/ mice
up to 15 mo of age.
Overall, the present findings support a potential role
for changes in the redox status of neurons as a mech-
anism leading to loss of muscle mass and function
during aging. Since muscles of SynTgSod1/ mice lack
CuZnSOD, the current results are also consistent with
our previous observation that absence of CuZnSOD
restricted to muscle is not sufficient to induce muscle
atrophy or fiber loss (21). The partial rescue of CuZnSOD
expression in motor neurons of the SynTgSod1/ mice
to 20% of WT levels dramatically reversed all aspects
of the accelerated neuromuscular aging phenotype
found in the Sod1/ mice, including the multiple
biochemical and physiological changes associated with
the accelerated aging. Use of the synapsin 1 promoter
in the transgenic mice allowed expression of CuZnSOD
in all tissues of SynTgSod1/ mice that contain syn-
apses, including brain, spinal cord, and sensory and
motor nerves, but excluded any role for other tissues
and cell types that might be anticipated to play an
essential role in maintenance of NMJs (e.g., Schwann
cells) or muscles (e.g., satellite cells). Although we
found no evidence of transgene expression in nonneu-
ronal tissues, as indicated by immunoblot analysis and
IHC and enzymatic studies, a comprehensive analysis of
the localization of the hSOD1 expression in neurons
has not been completed. Thus, we cannot rule out the
possibility that CuZnSOD expression in other cell types
within the nerve contributes to the protection from
NMJ and muscle decline. The observation that the
relatively low expression levels (20%) of CuZnSOD in
the sciatic nerve of the SynTgSod1/ mice were suffi-
cient to rescue the accelerated muscle phenotype in the
Sod1/ is in accord with previous data showing that
expression of 25% of the SOD1 protein in neurons of
Sod1/mice rescues motor neuron neuropathy (32) and
suggests that SOD1 in motor neurons of WT mice is in
relative excess. We speculate that this reflects a specific
requirement to protect neural tissue, in particular, against
superoxide- or peroxynitrite-induced degeneration, since
complete deletion of SOD1 in muscle fibers does not
induce overt degenerative changes in that tissue (21).
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Taken together with our previous studies of muscle-
specific CuZnSOD deletion (21), these data indicate
that the increase in oxidative damage in muscle from
Sod1/ mice derives from changes in the redox status
of neurons and hence potentially from a lack of appro-
priate innervation of the muscle. Isolated mitochondria
from muscle of Sod1/ mice have been shown to
release increased amounts of hydrogen peroxide (11),
and this process has been assumed to be the source of
the increased ROS generation that leads to increased
oxidative damage in Sod1/ mice and also in aged WT
mice (10, 31). Data from the current study provide
further support for the conclusion that such changes in
the muscle of Sod1/ mice are secondary to neuronal
deficits, because they did not occur in the SynTgSod1/
mice where CuZnSOD was rescued only in the neurons.
A potential mechanism for these changes comes from a
study by Muller et al. (33), who demonstrated that
transsection of the motor nerve induces large and
sustained increases in the release of hydrogen peroxide
and other ROS from mitochondria isolated from the
denervated muscle. Thus, a logical hypothesis is that a
primary effect of absence of CuZnSOD in neurons is to
induce a functional denervation of muscle fibers that
leads to an increase in ROS generation by muscle
mitochondria, a consequent increase in oxidative dam-
age in muscle, and an activation of adaptive responses
to oxidative stress.
Clear evidence that the absence of CuZnSOD in
neurons in Sod1/ mice leads to functional denerva-
tion of muscle fibers, disruption of NMJs, and failure of
neuromuscular transmission was provided by the obser-
vation that direct muscle stimulation showed an in-
crease in maximum isometric force generation in mus-
cle of the Sod1/ mice that was not seen in muscles of
the SynTgSod1/ mice. In addition, both pre- and
postsynaptic NMJ structures were disrupted in the
Sod1/ mice but not in the SynTgSod1/ mice, and
the electrophysiological properties, such as synaptic
transmission at individual NMJs and muscle fiber re-
cruitment, were maintained in the SynTgSod1/ mice.
In support of the hypothesis that maintenance of the
integrity of NMJ structure is highly dependent on
CuZnSOD expression in neurons, we also found no
increase in the AChR- mRNA content in muscle from
the SynTgSod1/ mice. Our previous observations of
increased AChR mRNA levels in Sod1/ mice with no
increase in AChR protein level (11) was interpreted as
a failed attempt to up-regulate the NMJ components in
response to denervation in Sod1/ mice. The lack of a
compensatory increase observed in the present study in
AChR mRNA in the SynTgSod1/ mice suggests that
there is no NMJ degeneration in this model. Thus, it
appears that the absence of CuZnSOD in motor neu-
rons specifically leads to disruption of motor neuron
and NMJ structure and function. Several experimental
models that lead to fragmentation and disruption of
AChR and NMJs have been shown to induce a pheno-
type that resembles sarcopenia. These include deple-
tion of the nerve-derived organizer of postsynaptic
differentiation agrin (17), enhanced degradation of
agrin through overexpression of neurotrypsin (18),
and a reduction in the expression of the postsynaptic
tyrosine kinase receptor B (TrkB; ref. 19). TrkB is a
receptor for neurotrophic factors such as BDNF and
neurotrophin-4 and -5. Although the latter model ini-
tially appears to be myocyte specific, all these models
share the property of acting to disrupt communication
from the motor neuron to the muscle, leading to
fragmentation of the NMJ. It is tempting to speculate
that this reflects a final common pathway that is also
present in Sod1/ mice, although there are currently
no specific data in support of this notion.
Denervation and loss of NMJ integrity have been
implicated in the loss of muscle fibers and failure of
muscle force generation that occur with aging in hu-
mans and rodents (34–37). The model described
herein indicates that deficits in redox homeostasis in
motor nerves alone are sufficient to generate an aging
phenotype in skeletal muscle and NMJs, with no inde-
pendent contribution from muscle fibers, Schwann
cells, or other associated cell types. It is currently
unknown whether the age-related loss of muscle mass
and function that occur in older humans and animals
can similarly be attributed to deficits in motor neurons,
or whether age-related deficits in skeletal muscles or
other tissues play a role. This model potentially pro-
vides a powerful approach to help elucidate the roles of
tissue-specific defects in redox status in this important
area of muscle aging.
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